Indena and Hyris partner on portable genomic identification of botanicals

By Nathan Gray contact

- Last updated on GMT

Indena and Hyris partner on portable genomic identification of botanicals
Italian botanical ingredient supplier Indena has agreed a strategic cooperation agreement with UK-based biotech Hyris for developing new methods for the genomic identification of botanical species.

The agreement is based on unique sets of reagents for specific DNA sequences (known as bKITs) and the use of a miniaturised, portable device for the analysis of nucleic acids (known as bCUBE).

Indena said the joint development of specific identification methods, which can be used directly on-site at biomass collection sites, adds a pillar to its expertise in the traceability of its supply chain, through genomic identification of plant materials.

The Hyris platform offers the capability to perform full genetic analysis of biological samples in any kind of setting by incorporating all the needed hardware, software and reagents into a small cube that can be used as a fully portable testing laboratory to provide highly accurate results, reducing the time associated with traditional methods.


The system can be controlled by a mobile app, called bAPP, which provides a complete and user-friendly interface that allows the user to download the test protocol required for the desired analysis, check the reaction as it is happening, and receive immediate diagnostic information on the sample being examined.

As part of the strategic cooperation agreement, Indena will also acquire a minority shareholding position in Hyris Ltd, and will hold preferential access to the technology in the botanical derivatives industry.

As such, Indena holds preferential access, exclusive for the dietary supplement ingredient industry, to the ‘breakthrough’ genomic technology for botanical identification, it said.

“Both companies’ approach to quality and innovation fits perfectly in adding value in the most forefront way to better serve clients and partners who look for excellence in the botanical extracts space,”​ said Daniele Giavini, Indena Managing Director.

“The dietary supplement market and consumers need reassurance regarding the authenticity of the products they consume.”

Stefano Lo Priore, CEO of Hyris said the agreement validates the company’s strategy to build long term relationships with industry leaders in various application sectors of molecular biology.

“We welcome Indena’s decision to make a direct investment in the company as part of this agreement, and look forward providing value to our client in this challenging market segment,”​ he added.

Related topics: Botanicals, Suppliers

Related news

Show more

Related products

show more

The Ingredients Show 2019 NEC Birmingham

The Ingredients Show 2019 NEC Birmingham

William Reed | 01-Jan-2019 | Product Brochure

We’ve been bringing food and drink markets together for over 150 years. And the drive to
inform and serve our sectors that fuelled the launch of...

Indena’s approach in supporting sport nutrition

Indena’s approach in supporting sport nutrition

Indena: the botanical ingredient of Health Food industry | 22-Nov-2018 | Technical / White Paper

Edible plants confirm to be a paramount source of precious substances able to help in maintaining the overall wellbeing and complement the nutrition of...

Skin-Gut Axis: The Potential of Pomella®

Skin-Gut Axis: The Potential of Pomella®

LEHVOSS Nutrition– Gee Lawson | 02-Nov-2018 | Technical / White Paper

When skin is exposed to oxidative stress, the effectiveness of the endogenic antioxidant system can be significantly compromised. Pomegranate, a natural...

Decoding the Six Pathways of Ageing

Decoding the Six Pathways of Ageing

Gencor | 04-Oct-2018 | Technical / White Paper

The desire to extend lifespan has been around since the beginning of time and with the growing ageing population, more and more research is being conducted...

Related suppliers

Follow us

Featured Events

View more


View more